← SynDRA
BRD-K13629382
SynDRA canonical compound SYN0062646 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ACHE | OPRD1 | OPRM1 |
| Mechanism of action | acetylcholinesterase inhibitor |
All known targets
Mechanisms of action (all sources)
- acetylcholinesterase inhibitor
Cross-references
Synonyms
- eseroline-(-)
- Eseroline
- (-)-Eseroline
- Q22H41O18D
- CHEBI:48845
- MCV 4481
- NIH 10398
- RefChem:137866
- DTXCID801030561
- ESEROLINE, (-)-
- SCHEMBL150460
- UNII-Q22H41O18D
- SCHEMBL30142606
- BDBM93695
- cid_45479742
- BDBM50292538
- AKOS024282669
- NCGC00017362-02
- NCGC00142536-01
- AC-37403
- FE162095
- ST057526
- BRD-K13629382-051-06-6
- (3aS,8aR)-1,8,3a-trimethylpyrrolidino[2,3-b]indolin-5-ol
- eseroline
- エセロリン
- SMR001562119
- (-)-Eseroline (fumarate)
- CS-0103581
- (-)-seroline (fumarate)
- (-)-Eseroline fumarate
- T73930
- HY-129101
- VCA31073
- orb1983349
- MLS002695961
Look up BRD-K13629382 in the interactive SynDRA portal →